Evidence map›Paper›PMID 38956805›Full record

Trial reportEuropean journal of sport science2024

Does a broad-spectrum cannabidiol supplement improve performance in a 10-min cycle ergometer performance-test?

Scott H Gillham, Lynn Starke, Lauren Welch, Edward Mather, Thomas Whitelegg, Neil Chester, Daniel J Owens, Theodoros Bampouras, Graeme L Close

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in European journal of sport science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Scott H GillhamResearch Institute for Sport and Exercise Sciences, Liverpool John Moores University, Liverpool, UK.ORCID https://orcid.org/0000-0002-1745-0118
Lynn StarkeResearch Institute for Sport and Exercise Sciences, Liverpool John Moores University, Liverpool, UK.
Lauren WelchResearch Institute for Sport and Exercise Sciences, Liverpool John Moores University, Liverpool, UK.
Edward MatherResearch Institute for Sport and Exercise Sciences, Liverpool John Moores University, Liverpool, UK.
Thomas WhiteleggResearch Institute for Sport and Exercise Sciences, Liverpool John Moores University, Liverpool, UK.
Neil ChesterResearch Institute for Sport and Exercise Sciences, Liverpool John Moores University, Liverpool, UK.
Daniel J OwensResearch Institute for Sport and Exercise Sciences, Liverpool John Moores University, Liverpool, UK.
Theodoros BampourasResearch Institute for Sport and Exercise Sciences, Liverpool John Moores University, Liverpool, UK.
Graeme L CloseResearch Institute for Sport and Exercise Sciences, Liverpool John Moores University, Liverpool, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cannabidiol (CBD) is a non-intoxicating phytocannabinoid which has been proposed to possess anti-inflammatory and analgesic properties. Given the potential for perceptions of pain to limit exercise performance, the aim of the present study was to investigate if 3 weeks of daily CBD supplementation (150 mg day

Indexed as

Athletic PerformanceCannabidiolDietary SupplementsHeart RateLactic AcidAdultDouble-Blind MethodExercise TestFemaleHumansMalePhysical ExertionYoung AdultCannabidiolLactic Acidanti‐dopingperformanceRPEsupplementation

Identifiers

PMID38956805
PMCPMC11236031

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.